Sotera Health Company Stock News

CLEVELAND, May 19, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory service

Sotera Health Company (NASDAQ:SHC ) Q1 2022 Results Conference Call May 5, 2022 9:00 AM ET Company Participants Michael Petras - Chairman and CEO Scott Leffler - CFO Conference Call Participants Sean

SHC earnings call for the period ending March 31, 2022.

Sotera Health Company (SHC) delivered earnings and revenue surprises of 15.79% and 2.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Sotera Health Company (SHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Sotera Health Company (SHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Charles River (CRL) delivered earnings and revenue surprises of 1.48% and 0.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Sotera Health Company (SHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sotera Health (NASDAQ:SHC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 2 0 0 Last 30D

Upgrades According to Morgan Stanley, the prior rating for Royalty Pharma PLC (NASDAQ:RPRX) was changed from Equal-Weight to Overweight. In the fourth quarter, Royalty Pharma showed an EPS of $0.80, c

Over the past 3 months, 5 analysts have published their opinion on Sotera Health (NASDAQ:SHC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a co

Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48, compared to year-ago q

Sotera Health <> is trading lower on Wednesday after Barclays downgraded the life sciences firm to Equal Weight from Overweight, citing the legal issues faced by the company…

Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth quarter, compared to $0.31 in